Event Brief
May 12, 2026 at 4:03 AM ET
Daiichi Sankyo bets on new cancer drugs for growth
By The BriefBrief
Daiichi Sankyo plans to more than double oncology revenue by 2030 with new cancer drugs.
WHO: Daiichi Sankyo
WHAT: Company strategy to expand oncology revenue using new cancer drugs
WHEN: May 12, 2026 at 3:34 AM ET
WHERE: Japan
WHY: What the company is doing is intended to drive future oncology growth.
Reporting from 1 identified publisher for this event.
View all 1 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Singaporean pleads guilty to live upskirt camera feed
Desmond Han Jiancong
May 12, 2026 at 4:05 AM ET
EQT to buy Japan restaurant review operator for $3.7b
Eqt
May 12, 2026 at 4:05 AM ET
Mitsubishi Heavy expects profit surge as Japan eases arms rules
Mitsubishi Heavy
May 12, 2026 at 4:05 AM ET
Two ex-Carillion finance directors fined by accountancy regulator
Carillion
May 12, 2026 at 4:03 AM ET
Page 19284 of 21409
Same format. Every time.
Continue reading — sign in or create a free account with
